KEMSA Grilled Over Missing COVID-19 Stock Records

The Kenya Medical Supplies Authority (KEMSA) has come under scrutiny for failing to provide key documentation related to COVID-19 stock, including batch numbers and inventory records, as flagged in the Auditor-General’s report for the 2020/2021 financial year.

Appearing before the Public Investments Committee on Social Services, Administration and Agriculture (PIC-SSAA) on Tuesday, July 22, 2025, KEMSA Chief Executive Officer Dr. Wago Ejersa faced tough questions from lawmakers about gaps in stock and cash management.

The Committee, chaired by Navakholo MP Emmanuel Wangwe, demanded full documentation supporting the authority’s handling of pandemic supplies. Dr. Ejersa acknowledged the gaps but attributed them to emergency procurement during the height of the COVID-19 crisis.

“The pandemic led to accelerated procurement, and in some cases, documentation from suppliers was delayed. However, we have since launched a compliance audit and revised our internal controls,” said Dr. Ejersa.

He added that KEMSA had taken steps to improve accountability, including the introduction of a stronger inventory control system, better quality assurance procedures, and enhanced warehouse management.

Addressing concerns on cash handling, the CEO told MPs that KEMSA has automated its imprest system to allow real-time tracking and promote transparency. “We are committed to operational excellence,” he said.

On foreign exchange losses during international procurements, Dr. Ejersa said a new policy now requires all government-funded suppliers to quote prices in Kenyan Shillings to prevent further currency-related setbacks.

While acknowledging the ongoing reforms at the Authority, MP Wangwe stressed the importance of full accountability.

“The steps taken are commendable, but accountability must be total. This Committee will continue to work with KEMSA to ensure all audit recommendations are fully implemented and public trust is restored,” he said.